Jobs / United States / Novartis Pharmaceuticals Corporation
Executive Clinical Program Leader - Translational Clinical Oncology
Novartis Pharmaceuticals Corporation · 🇺🇸 Cambridge (USA)
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles2 certified filings for “Study Leader” (Natural Sciences Managers) in NJ: $141k–$141k, median $141k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary Executive Clinical Program Leader - Translational Clinical Oncology Location: Cambridge, MA, USA Work Arrangement: Onsite The Executive Clinical Program Leader (ECPL) provides strategic medical and scientific leadership for the development of multiple experimental agents within the Translational Clinical Oncology (TCO) portfolio. The role spans from early target identification through transition into later-stage development, partnering closely with development teams to accelerate decision-making and portfolio advancement. The ECPL also provides scientific and clinical expertise to evaluate external innovation opportunities and business development initiatives. Job Description Key Responsibilities • Provide strategic medical and scientific leadership across early oncology development programs. • Represent Translational Clinical Oncology programs at internal governance and leadership boards. • Lead clinical strategy development and provide senior clinical input for clinical studies and preclinical research projects. • Review and provide feedback on key study documents, including protocols, investigator brochures, and regulatory submissions. • Contribute scientific and clinical expertise to business development, licensing evaluations, and portfolio reviews. • Lead and oversee external collaborations and strategic partnerships. • Mentor colleagues and serve as an expert resource across Biomedical Research and the broader organization. • Ensure the safe, ethical, and compliant conduct of clinical trials in accordance with GCP and company procedures. • Engage with external experts, investigators, and health authorities in support of early oncology clinical development. • Contribute to scientific publications, abstracts, and presentations for internal and external audiences. Essential Requirements • MD required; MD/PhD preferred. • Board certification (or equivalent expertise) in Hematology-Oncology. • 7+ years of experience leading complex global early-phase hematology-oncology clinical programs within the pharmaceutical or biotechnology industry. • Strong experience in translational hematology/oncology and clinical research. • Recognized scientific and clinical expertise demonstrated through publications and professional contributions. • Broad knowledge of oncology drug development and clinical trial execution. • Excellent written and verbal communication skills. • Proven leadership and people management experience. • Strong mentoring and talent development capabilities. • High ethical standards and commitment to improving outcomes for patients with cancer Rewards At Novartis, we’re committed to reimagining medicine together - and rewarding the people who make it happen. The rewards of being part of our team go far beyond base pay and incentives. We also offer a variety of competitive benefits in kind to help you thrive personally and professionally, such as insurance plans, retirement plans, wellbeing resources and global recognition programs. In addition, we provide flexible and hybrid working options, where possible, and a minimum of 14 weeks paid parental leave. Expected Annual Base Salary Range for role: • USA: $288,400.00 - 535,600.00 USD Annual The salary offered is determined based on gender-neutral objectives, such as relevant skills, competencies and experience in accordance with the Novartis pay setting policy and upon joining Novartis will be reviewed periodically. In addition to your base salary, you may be eligible for a performance-based bonus depending on certain performance parameters. Further details will be provided during the application process. Pay equity is a fundamental principle of our employment policy and reflects our commitment to cre